Cellulite and focused extracorporeal shockwave therapy for non-invasive body contouring: a randomized trial

Karsten Knobloch, Beatrice Joest, Robert Krämer, Peter M Vogt, Karsten Knobloch, Beatrice Joest, Robert Krämer, Peter M Vogt

Abstract

Introduction: Focused extracorporeal shockwave therapy (ESWT) has been demonstrated to improve wound healing and skin regeneration such as in burn wounds and scars. We hypothesized that the combination of focused ESWT and a daily gluteal muscle strength program is superior to SHAM-ESWT and gluteal muscle strength training in moderate to severe cellulite.

Methods: This was a single-center, double-blinded, randomized-controlled trial. For allocation of participants, a 1:1 ratio randomization was performed using opaque envelopes for the concealment of allocation. Eligible patients were females aged 18-65 years with cellulite. The primary outcome parameter was the photo-numeric Cellulite Severity Scale (CSS) determined by two blinded, independent assessors. The intervention group (group A) received six sessions of focused ESWT (2,000 impulses, 0.35 mJ/mm(2), every 1-2 weeks) at both gluteal and thigh regions plus specific gluteal strength exercise training. The control group (group B) received six sessions of SHAM-ESWT plus specific gluteal strength exercise training.

Results: The CSS in group A was 10.9 ± 3.8 (mean ± SE) before intervention and 8.3 ± 4.1 after 12 weeks (P = 0.001, 2.53 improvement, 95% confidence interval (CI) 1.43-3.62). The CSS in group B was 10.0 ± 3.8 before intervention and 10.1 ± 3.8 after 12 weeks (P = 0.876, 95% CI 1.1-0.97). The change of the CSS in group A versus group B was significantly different (P = 0.001, -24.3 effect size, 95% CI -36.5 to -12.1).

Conclusion: The combination of non-invasive, focused ESWT (0.35 mJ/mm(2), 2,000 impulses, 6 sessions) in combination with gluteal strength training was superior to gluteal strength training and SHAM-ESWT in moderate to severe cellulite in terms of the CSS in a 3-month perspective. Long-term results have to be evaluated in terms of the sustainability of these effects.

Figures

Fig. 1
Fig. 1
CONSORT patient flow chart. Modified with permission from Knobloch et al. [14]
Fig. 2
Fig. 2
Placement of the shockwave probe from distal to proximal on both thighs
Fig. 3
Fig. 3
First exercise (15 repetitions per leg twice a day over 12 weeks)
Fig. 4
Fig. 4
Second exercise (15 repetitions per leg twice a day over 12 weeks)
Fig. 5
Fig. 5
Improvement of the Cellulite Severity Score from 15 to 7 in a female patient suffering from cellulite before and 3 months after six sessions of focused extracorporeal shockwave therapy (0.35 mJ/mm2)
Fig. 6
Fig. 6
Improvement of the Cellulite Severity Score from 12 to 2 in a female patient suffering from cellulite before and 3 months after six sessions of focused extracorporeal shockwave therapy (0.35 mJ/mm2)
Fig. 7
Fig. 7
Improvement of the Cellulite Severity Score from 10 to 6 in a female patient suffering from cellulite before and 3 months after six sessions of focused extracorporeal shockwave therapy (0.35 mJ/mm2)
Fig. 8
Fig. 8
No significant improvement of the Cellulite Severity Score from 13 to 11 in a female patient suffering from cellulite before and 3 months after six sessions of sham extracorporeal shockwave therapy (0.01 mJ/mm2, control group)
Fig. 9
Fig. 9
No improvement of the Cellulite Severity Score from 4 to 5 in a female patient suffering from cellulite before and 3 months after six sessions of sham extracorporeal shockwave therapy (0.01 mJ/mm2, control group)
Fig. 10
Fig. 10
Change of the Cellulite Severity Score before and 3 months after six sessions of either focused extracorporeal shockwave therapy (ESWT) (0.35 mJ/mm2, intervention group) or SHAM-ESWT (0.01 mJ/mm2, control group)

References

    1. Proebstle TM. Cellulite. Hautarzt. 2010;61(10):864–872. doi: 10.1007/s00105-010-1986-8.
    1. Emanuele E, Minoretti P, Altabas K, Gaeta E, Altabas V. Adiponectin expression in subcutaneous adipose tissue is reduced in women with cellulite. Int J Dermatol. 2011;50(4):412–416. doi: 10.1111/j.1365-4632.2010.04713.x.
    1. Hexsel D, Hexsel CL, Weber MB. Social impact of cellulite and its impact on quality of life. In: Goldman MP, Hexsel D, editors. Cellulite. Pathophysiology and treatment. 2. London: Informa Healthcare; 2010.
    1. Christ C, Brenke G, Sattler G, et al. Steigerung der Hautelastizität und Revitalisierung der Dermis bei Cellulite und Bindegewebsschwäche durch die extrakorpoale Acoustic Wave Therapy (AWT) Ästhetische Dermatologie. 2008;1:2–10.
    1. Sattler G, Pohl U, Raegener K. Pilotstudie akustische Wellentherapie (AWT) bei Cellulite. Äathetische Dermatologie. 2008;2:16–25.
    1. Bae H, Kim J. Clinical outcomes of extracorporeal shock wave therapy in patients with secondary lymphedema: a pilot study. Ann Rehabil Med. 2013;37(2):229–234. doi: 10.5535/arm.2013.37.2.229.
    1. Tinazzi E, Amelio E, Marangoni E, et al. Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol Int. 2011;31:651–656. doi: 10.1007/s00296-009-1339-z.
    1. Siems W, Grune T, Voss P, Brenke R. Anti-fibrosclerotic effects of shock wave therapy in lipedema and cellulite. BioFactors. 2005;24(1–4):275–282. doi: 10.1002/biof.5520240132.
    1. Angehrn F, Kuhn C, Voss A. Can cellulite be treated with low-energy extracorporal shock wave therapy? Clin Interv Aging. 2007;2(4):623–630.
    1. Kuhn C, Angehrn F, Sonnabend O, Voss A. Impact of extracorporal shock waves on the human skin with cellulite: a case study of an unique instance. Clin Interv Aging. 2008;3(1):201–210.
    1. Adatto M, Adatto-Neilson R, Servant JJ, Vester J, Novak P, Krotz A. Controlled, randomized study evaluating the effects of treating cellulite with AWT®/EPAT®. J Cosmet Laser Ther. 2010;12:176–182. doi: 10.3109/14764172.2010.500392.
    1. CONSORT: (Last accessed November 14, 2013).
    1. Schulz KF, Altman DG, Moher D, for the CONSORT group CONSORT statement: updated guidelines for reporting parallel group randomized trials. BMC Med. 2010;2010(8):18. doi: 10.1186/1741-7015-8-18.
    1. Knobloch K, Joest B, Vogt PM. Cellulite and extracorporeal shockwave therapy (CelluShock 2009)—a randomized trial. BMC Womens Health. 2010;10:29. doi: 10.1186/1472-6874-10-29.
    1. Hexsel DM, Dal’Forno TD, Hexsel CL. A validated photonumeric cellulite severity scale. J Eur Acad Dermatol Venereol. 2009;23(5):523–528. doi: 10.1111/j.1468-3083.2009.03101.x.
    1. Lautenschläger H. Skin diagnosis—based on measuring results. Kosmetik Int. 2008;10:54–56.
    1. Lautenschläger H. Skin analysis—customer interview to complement measurements. Kosmetik Int. 2004;8:72–74.
    1. Lautenschläger H. Skin analysis—with the support of modern instruments. Kosmetik Int. 2003;3:102–104.
    1. Lautenschläger H. Instruments for skin analysis. Kostmetik Int. 2001;1:90.
    1. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994;272:125–128. doi: 10.1001/jama.1994.03520020051014.
    1. Hexsel DM, Abreu M, Rodrigues TC, Soirefmann M, do Prado DZ, Gamboa MM. Side-by-side comparison of areas with and without cellulite depressions using magnetic resonance imaging. Dermatol Surg. 2009;35(10):1471–1477. doi: 10.1111/j.1524-4725.2009.01260.x.
    1. Kim IG, Lee JY, Lee DS, Kwon JY, Hwang JH. Extracorporeal shockwave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis. J Vasc Res. 2013;50(2):124–133. doi: 10.1159/000343699.
    1. Raabe O, Shell K, Goessl A, et al. Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. Am J Stem Cells. 2013;2(1):62–73.
    1. Tinazzi E, Amelio E, Marangoni E, et al. Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol Int. 2011;31(5):651–656. doi: 10.1007/s00296-009-1339-z.
    1. Russe-Wilflingseder K, Russe E, Vester JC, Haller G, Novak P, Krotz A. Placebo controlled, prospectively randomized, double-blinded study for the investigation of the effectiveness and safety of the acoustic wave therapy (AWT) for cellulite treatment. J Cosmet Laser Ther. 2013;15(3):155–162. doi: 10.3109/14764172.2012.759235.
    1. Jackson RF, Roche GC, Shanks SC. A double-blind, placebo-controlled randomized trial evaluating the ability of low-level laser therapy to improve the appearance of cellulite. Lasers Surg Med. 2013;45(3):141–147. doi: 10.1002/lsm.22119.
    1. Truitt A, Elkeeb L, Ortiz A, Saedi N, Echague A, Kelly KM. Evaluation of a long pulsed 1064-nm Nd:YAG laser for improvement in appearance of cellulite. J Cosmet Laser Ther. 2012;14(3):139–144. doi: 10.3109/14764172.2012.685480.
    1. Mlosek RK, Wozniak W, Malinowska S, Lewandowski M, Nowicki A. The effectiveness of anticellulite treatment using tripolar radiofrequency monitored by classic and high-frequency ultrasound. J Eur Acad Dermatol Venerol. 2012;26(6):696–703. doi: 10.1111/j.1468-3083.2011.04148.x.

Source: PubMed

3
Abonnere